Loading...
Loading...
Application UK00913655337 · Registered
| Application Number | UK00913655337 |
| Status | Registered |
| Owner | Oculus Technologies of México S.A. de C.V. |
| Filed | 2015-01-19 |
| Registered | 2015-11-15 |
| Renewal Due | 2035-01-19 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. ADVACYN is currently a registered UK trademark, with renewal due on 2035-01-19. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations for wound care; Sanitary preparations for wound care; Plasters, materials for dressings; Material for stopping teeth, dental wax; Disinfectants; Disinfectants for wound care; Disinfectants for medical and dental instruments; hand, wound healing and wound irrigation sterilization agent; The aforesaid goods relating to wound healing and for human use.
Surgical, medical and dental apparatus and instruments, artificial limbs, eyes and teeth; Surgical, medical and dental apparatus and instruments for wound healing; Orthopedic articles; Orthopedic articles for wound care; Suture materials; Suture materials for wound care; The aforesaid goods relating to wound healing and for human use.
Medical services; Services in the field of hygienic and beauty care for human beings; Wound care management; Agriculture, horticulture and forestry services; advise, Consultancy and information regarding the aforesaid services, Including via electronic networks and the internet; The aforesaid relating to wound healing and for human use.
'ADVACYN' is a registered trademark on the UK IPO register, owned by Oculus Technologies of México S.A. de C.V.. The application (UK00913655337) was filed on 19 January 2015 and registered on 15 November 2015. The registration is set to expire on 19 January 2035.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus); Class 44 (medical, veterinary & beauty services).
The trademark is represented by Joost Muylle.
UK trademark UK00913655337 for the mark 'ADVACYN' in Class 5, 10, 44 is recorded on the UK IPO register as owned by Oculus Technologies of México S.A. de C.V.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00913655337 for the mark 'ADVACYN' as registered.
UK trademark UK00913655337 for the mark 'ADVACYN' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 10 (medical & surgical apparatus); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceutical preparations for wound care; Sanitary preparations for wound care; Plasters, materials for dressings; Material for stopping teeth, dental wax; Disinfectants; Disinfectants for wound care; Disinfectants for medical and dental instruments; hand, wound healing and wound irrigation sterilization…
UK trademark UK00913655337 for the mark 'ADVACYN' was filed at the UK IPO on 19 January 2015 and registered on 15 November 2015.
UK trademark UK00913655337 for the mark 'ADVACYN' is currently recorded as valid until 19 January 2035, at which point it will need to be renewed with the UK IPO to remain in force.
Joost Muylle is listed as the attorney / representative of record for UK trademark UK00913655337 for the mark 'ADVACYN' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.